Developer docs
API playgroundTry for free, no card

Search company profiles

labtest.bio

Full company profile

uuid02lzgqo

Namestring
labtest.bio
Legal namestring
Pro-Lab Diagnostics
Websiteurl
labtest.bio
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Labtest Bio, operating under the legal entity Pro-Lab Diagnostics, is a US-based molecular diagnostic reference laboratory specializing in Nucleic Acid Amplification Test (NAAT) based infectious disease testing. The company operates three primary processing sites — Georgetown TX, Irvine CA, and Princeton NJ — plus a Round Rock TX data center, providing nationwide next-day turnaround. Its core chemistry platform is the proprietary ProAmpHT Isothermal Amplification technology, supplemented by PCR, supporting a customizable menu of approximately 10 diagnostic panels tailored to specific clinical indications.

The company sells primarily B2B into healthcare provider segments including OBGYN practices, skilled nursing facilities (SNFs), and urgent care clinics, using a sales-led go-to-market motion. As a differentiator, Labtest Bio offers its Pro LIMS electronic medical record (EMR) integration at no cost, embedding test ordering and result delivery into customer clinical workflows. The lab is credentialed under CLIA, COLA, and ISO 13485:2016, qualifying it to serve institutional and government-payor work and signaling adherence to high-complexity testing standards.

Labtest Bio's revenue mechanics follow a per-test reference laboratory model with no public pricing disclosed. The company is privately held, reports no funding rounds or M&A activity in available data, and operates with an 11–50 employee base that includes PhD-level lab directors and Medical Laboratory Scientist certified staff. Strategic product activity over 2021–2022 included COVID-19 variant detection validation (December 2021) and a customized C. difficile panel launch (December 2022), indicating active menu expansion beyond pandemic-era respiratory testing.

Short descriptiontext

Labtest Bio is a US molecular diagnostic reference laboratory offering customizable NAAT-based infectious disease testing panels with next-day turnaround for healthcare providers including OBGYNs, skilled nursing facilities, and urgent care clinics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGeorgetown, United States
HQ citystring
Georgetown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostic testing, clinical reference laboratory, NAAT pathogen detection, infectious disease testing, antimicrobial resistance testing
Industry3 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAD
Microbiology & Infectious Disease Testing Laboratories
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Molecular Diagnostic Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Molecular Diagnostic Testing Services
TypeSubscription Recurring
Description

Core revenue from molecular diagnostic laboratory testing services delivered to healthcare providers. Tests include customizable panels for infectious diseases, antibiotic resistance profiling, and confirmatory testing. Revenue is generated per test, with next-day turnaround and free sample pickup logistics.

labtest.bio
2Affordable Cash Pay / Patient Payment Portal
TypeOne Time License
Description

Direct patient billing through a dedicated patient payment portal offering transparent pricing and dispute resolution for uninsured or out-of-pocket patients.

labtest.bio
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Not publicly disclosed
ModelOther
Notes

Pricing information is not publicly listed. Company offers 'affordable cash pay' with transparent billing and dispute resolution. Specific price points require direct inquiry.

labtest.bio
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Labtest Bio is a national molecular reference laboratory that delivers customizable NAAT (Nucleic Acid Amplification Test) diagnostic panels — covering UTIs, C. difficile, respiratory infections, GI infections, wound infections, vaginitis, candidiasis, nail fungus, STIs, and antibiotic resistance — to healthcare providers. Powered by proprietary ProAmpHT isothermal amplification technology and supported by free Pro LIMS EMR integration, the lab provides next-morning (24-hour) results with same-day sample pickup.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Next-day diagnostic results — faster than leading national labs
+2 more records
Product overview1 text field

Labtest Bio is a National Molecular Reference Laboratory providing a complete and dedicated NAAT (Nucleic Acid Amplification Test) program. The core offering consists of state-of-the-art molecular diagnostic panels powered by the proprietary ProAmpHT Isothermal Amplification Technology, delivering next-day results. The company offers ten customizable diagnostic panels: Candidiasis, Vaginitis/Vaginosis, C. difficile, UTI, Wound Infection, Antibiotic Resistance, Gastrointestinal (GI), Respiratory Pathogen (RPP), Nail Fungus, and STI panels. These panels are supported by the Pro LIMS lab software platform featuring free EMR integration. The company operates three strategically located facilities nationwide (Texas, California, New Jersey) and emphasizes rapid turnaround times with next-morning results.

Product and service10 records
1Candidiasis Panel
CategoryDiagnostic Test Panel
Description

Customizable molecular diagnostic panel targeting Candida species including C. albicans, C. dubliniensis, C. glabrata, C. parapsilosis, C. tropicalis, C. lusitaniae, and C. krusei, intended for clinicians diagnosing yeast infections.

2Vaginitis/Vaginosis Panel
CategoryDiagnostic Test Panel
Description

Customizable panel targeting vaginal pathogens including Gardnerella vaginalis, Lactobacillus species, and other bacteria associated with bacterial vaginosis, intended for OBGYN and women's health providers.

3C. difficile Panel
CategoryDiagnostic Test Panel
Description

Molecular test panel detecting C. difficile Toxin A and Toxin B with 24-hour turnaround for rapid diagnosis of C. diff infection, intended for clinicians managing infectious diarrhea.

4UTI Panel
CategoryDiagnostic Test Panel
Description

Customizable urinary tract infection panel with basic targets (Acinetobacter, Candida, E. coli, Enterococcus, Klebsiella, Proteus, Pseudomonas, Staphylococcus, Streptococcus) and extended targets including additional pathogens, intended for urgent care and primary care clinicians.

5Wound Infection Panel
CategoryDiagnostic Test Panel
Description

Customizable panel targeting wound infection pathogens including Bacteroides, Staphylococcus epidermidis, Clostridium, Finegoldia magna, and other wound-associated organisms, intended for clinicians managing chronic or acute wound infections.

6Antibiotic Resistance Panel
CategoryDiagnostic Test Panel
Description

Molecular panel detecting resistance genes including beta-lactam resistance (CTX-M, IMP, KPC, NDM, OXA-48, VIM), methicillin resistance (mecA, mecC), and vancomycin resistance (vanA, vanB), intended to support antimicrobial stewardship for clinicians and pharmacists.

7Gastrointestinal (GI) Panel
CategoryDiagnostic Test Panel
Description

Comprehensive GI pathogen panel detecting Campylobacter, Listeria, Salmonella, Shigella, Cryptosporidium, Giardia, Norovirus, Rotavirus, Adenovirus, and parasites, intended for clinicians diagnosing infectious gastroenteritis.

8Respiratory Pathogen Panel (RPP)
CategoryDiagnostic Test Panel
Description

Comprehensive respiratory panel detecting viral pathogens (Influenza, RSV, Coronavirus, Rhinovirus, Adenovirus, Parainfluenza, Metapneumovirus), bacterial pathogens (Bordetella, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella), and fungi, intended for clinicians diagnosing respiratory infections.

9Nail Fungus Panel
CategoryDiagnostic Test Panel
Description

Molecular diagnostic panel targeting dermatophytes and fungi causing nail infections including Trichophyton rubrum, Aspergillus, Candida, Microsporum, and Epidermophyton, intended for dermatology and podiatry clinicians.

10STI Panel
CategoryDiagnostic Test Panel
Description

Sexually transmitted infection panel detecting Chlamydia, Neisseria gonorrhoeae, Trichomonas, Treponema pallidum, Ureaplasma, and herpesviruses (HSV-1, HSV-2, VZV, CMV), intended for OBGYN, primary care, and urgent care clinicians.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Pro LIMS (HIPAA-compliant Lab Software)
Strategic tierCoreTypeTechnology or Integration
Description

Pro LIMS is a HIPAA-compliant laboratory information management system integrated into Labtest Bio's workflow. The company offers free EMR/LIS integration with Pro LIMS, enabling streamlined test ordering and resulting for clinical partners. This integration is a core component of the company's value proposition for healthcare providers.

labtest.bio
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

One of the two dominant U.S. clinical reference laboratory networks, offering extensive molecular infectious disease testing panels and nationwide logistics. Directly comparable as a national molecular reference lab serving the same clinician base, though far larger and broader in scope than Labtest Bio.

TypeBroad incumbent
Description

Academic medical center-affiliated national reference laboratory offering extensive esoteric and molecular infectious disease testing to hospitals and reference clients. Comparable as a reference lab serving complex clinical diagnostics needs, though broader and more hospital-channel-focused than Labtest Bio.

TypeEmerging player
Description

An independently owned molecular reference laboratory offering PCR-based STI, UTI, and women's health panels to clinicians with a similar focus on specialty infectious disease testing. A near-direct comparable in size and customer targeting to Labtest Bio's customizable panel model.

4Viracor Eurofins
TypeDirect peer
Description

A specialty molecular and immunology reference laboratory with a similar focus on complex infectious disease and immune-mediated testing for clinicians. Competes head-to-head in NAAT-based infectious disease panels with a specialty-lab service model analogous to Labtest Bio's customization and rapid turnaround positioning.

TypeDirect peer
Description

A specialty reference laboratory offering molecular infectious disease, toxicology, and pharmacogenomic testing with rapid turnaround to clinicians. Closely comparable mid-size specialty molecular lab competing for similar OBGYN, urgent care, and pain/ID physician relationships.

TypeBroad incumbent
Description

The other dominant U.S. national reference laboratory, offering PCR/NAAT-based infectious disease panels and routine molecular testing to physicians, hospitals, and SNFs. Operates a nationwide patient service center and logistics network that Labtest Bio's three facilities cannot match in convenience.

TypeBroad incumbent
Description

Hospital-affiliated national esoteric reference laboratory offering specialty molecular and infectious disease testing globally. Comparable as a reference laboratory serving clinicians with complex diagnostics, though anchored in academic hospital distribution rather than OBGYN/SNF channels.

TypeBroad incumbent
Description

A national full-service clinical reference laboratory with a strong footprint in women's health, oncology, and infectious disease molecular diagnostics. Competes for similar OBGYN and specialty clinician customers with broader routine testing capabilities than Labtest Bio's infectious disease-focused menu.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

labtest.bio

Molecular Diagnostic Laboratory Serviceslabtest.bio

Labtest Bio is a US molecular diagnostic reference laboratory offering customizable NAAT-based infectious disease testing panels with next-day turnaround for healthcare providers including OBGYNs, skilled nursing facilities, and urgent care clinics.

What labtest.bio does

Labtest Bio, operating under the legal entity Pro-Lab Diagnostics, is a US-based molecular diagnostic reference laboratory specializing in Nucleic Acid Amplification Test (NAAT) based infectious disease testing. The company operates three primary processing sites — Georgetown TX, Irvine CA, and Princeton NJ — plus a Round Rock TX data center, providing nationwide next-day turnaround. Its core chemistry platform is the proprietary ProAmpHT Isothermal Amplification technology, supplemented by PCR, supporting a customizable menu of approximately 10 diagnostic panels tailored to specific clinical indications.

The company sells primarily B2B into healthcare provider segments including OBGYN practices, skilled nursing facilities (SNFs), and urgent care clinics, using a sales-led go-to-market motion. As a differentiator, Labtest Bio offers its Pro LIMS electronic medical record (EMR) integration at no cost, embedding test ordering and result delivery into customer clinical workflows. The lab is credentialed under CLIA, COLA, and ISO 13485:2016, qualifying it to serve institutional and government-payor work and signaling adherence to high-complexity testing standards.

Labtest Bio's revenue mechanics follow a per-test reference laboratory model with no public pricing disclosed. The company is privately held, reports no funding rounds or M&A activity in available data, and operates with an 11–50 employee base that includes PhD-level lab directors and Medical Laboratory Scientist certified staff. Strategic product activity over 2021–2022 included COVID-19 variant detection validation (December 2021) and a customized C. difficile panel launch (December 2022), indicating active menu expansion beyond pandemic-era respiratory testing.

labtest.bio firmographics

Firmographics
Name
labtest.bio
Legal name
Pro-Lab Diagnostics
Website
https://labtest.bio
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Labtest Bio is a US molecular diagnostic reference laboratory offering customizable NAAT-based infectious disease testing panels with next-day turnaround for healthcare providers including OBGYNs, skilled nursing facilities, and urgent care clinics.
Ownership category
akta.pro rank

labtest.bio industry classification

Industry
Product category
Molecular Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAD
Microbiology & Infectious Disease Testing Laboratories

Keywords

  • Molecular diagnostic testing
  • Clinical reference laboratory
  • NAAT pathogen detection
  • Infectious disease testing
  • Antimicrobial resistance testing

Where labtest.bio is headquartered

Location

Headquarters

HQ city
Georgetown
HQ country
United States
HQ region
North America

Offices4 records

Markets served

labtest.bio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Molecular Diagnostic Testing Services: Core revenue from molecular diagnostic laboratory testing services delivered to healthcare providers. Tests include customizable panels for infectious diseases, antibiotic resistance profiling, and confirmatory testing. Revenue is generated per test, with next-day turnaround and free sample pickup logistics.
  2. Affordable Cash Pay / Patient Payment Portal: Direct patient billing through a dedicated patient payment portal offering transparent pricing and dispute resolution for uninsured or out-of-pocket patients.

Pricing tiers

ModelBillingPrice
Other—Not publicly disclosed

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

labtest.bio product offering

Product offering

Core offering

Labtest Bio is a national molecular reference laboratory that delivers customizable NAAT (Nucleic Acid Amplification Test) diagnostic panels — covering UTIs, C. difficile, respiratory infections, GI infections, wound infections, vaginitis, candidiasis, nail fungus, STIs, and antibiotic resistance — to healthcare providers. Powered by proprietary ProAmpHT isothermal amplification technology and supported by free Pro LIMS EMR integration, the lab provides next-morning (24-hour) results with same-day sample pickup.

Product overview

Labtest Bio is a National Molecular Reference Laboratory providing a complete and dedicated NAAT (Nucleic Acid Amplification Test) program. The core offering consists of state-of-the-art molecular diagnostic panels powered by the proprietary ProAmpHT Isothermal Amplification Technology, delivering next-day results. The company offers ten customizable diagnostic panels: Candidiasis, Vaginitis/Vaginosis, C. difficile, UTI, Wound Infection, Antibiotic Resistance, Gastrointestinal (GI), Respiratory Pathogen (RPP), Nail Fungus, and STI panels. These panels are supported by the Pro LIMS lab software platform featuring free EMR integration. The company operates three strategically located facilities nationwide (Texas, California, New Jersey) and emphasizes rapid turnaround times with next-morning results.

Differentiator

Problem solved

Functional benefit

Products and services

  • Candidiasis Panel Customizable molecular diagnostic panel targeting Candida species including C. albicans, C. dubliniensis, C. glabrata, C. parapsilosis, C. tropicalis, C. lusitaniae, and C. krusei, intended for clinicians diagnosing yeast infections.
  • Vaginitis/Vaginosis Panel Customizable panel targeting vaginal pathogens including Gardnerella vaginalis, Lactobacillus species, and other bacteria associated with bacterial vaginosis, intended for OBGYN and women's health providers.
  • C. difficile Panel Molecular test panel detecting C. difficile Toxin A and Toxin B with 24-hour turnaround for rapid diagnosis of C. diff infection, intended for clinicians managing infectious diarrhea.
  • UTI Panel Customizable urinary tract infection panel with basic targets (Acinetobacter, Candida, E. coli, Enterococcus, Klebsiella, Proteus, Pseudomonas, Staphylococcus, Streptococcus) and extended targets including additional pathogens, intended for urgent care and primary care clinicians.
  • Wound Infection Panel Customizable panel targeting wound infection pathogens including Bacteroides, Staphylococcus epidermidis, Clostridium, Finegoldia magna, and other wound-associated organisms, intended for clinicians managing chronic or acute wound infections.
  • Antibiotic Resistance Panel Molecular panel detecting resistance genes including beta-lactam resistance (CTX-M, IMP, KPC, NDM, OXA-48, VIM), methicillin resistance (mecA, mecC), and vancomycin resistance (vanA, vanB), intended to support antimicrobial stewardship for clinicians and pharmacists.
  • Gastrointestinal (GI) Panel Comprehensive GI pathogen panel detecting Campylobacter, Listeria, Salmonella, Shigella, Cryptosporidium, Giardia, Norovirus, Rotavirus, Adenovirus, and parasites, intended for clinicians diagnosing infectious gastroenteritis.
  • Respiratory Pathogen Panel (RPP) Comprehensive respiratory panel detecting viral pathogens (Influenza, RSV, Coronavirus, Rhinovirus, Adenovirus, Parainfluenza, Metapneumovirus), bacterial pathogens (Bordetella, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella), and fungi, intended for clinicians diagnosing respiratory infections.
  • Nail Fungus Panel Molecular diagnostic panel targeting dermatophytes and fungi causing nail infections including Trichophyton rubrum, Aspergillus, Candida, Microsporum, and Epidermophyton, intended for dermatology and podiatry clinicians.
  • STI Panel Sexually transmitted infection panel detecting Chlamydia, Neisseria gonorrhoeae, Trichomonas, Treponema pallidum, Ureaplasma, and herpesviruses (HSV-1, HSV-2, VZV, CMV), intended for OBGYN, primary care, and urgent care clinicians.

Quantifiable outcome

  • Next-day diagnostic results — faster than leading national labs
  • +2 more outcomes

Companies that use labtest.bio

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

labtest.bio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

labtest.bio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pro LIMS (HIPAA-compliant Lab Software)coreTechnology or IntegrationPro LIMS is a HIPAA-compliant laboratory information management system integrated into Labtest Bio's workflow. The company offers free EMR/LIS integration with Pro LIMS, enabling streamlined test ordering and resulting for clinical partners. This integration is a core component of the company's value proposition for healthcare providers.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

labtest.bio competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: One of the two dominant U.S. clinical reference laboratory networks, offering extensive molecular infectious disease testing panels and nationwide logistics. Directly comparable as a national molecular reference lab serving the same clinician base, though far larger and broader in scope than Labtest Bio.
  • ARUP Laboratories: Academic medical center-affiliated national reference laboratory offering extensive esoteric and molecular infectious disease testing to hospitals and reference clients. Comparable as a reference lab serving complex clinical diagnostics needs, though broader and more hospital-channel-focused than Labtest Bio.
  • Laboratory Corporation of America (Labcorp): The other dominant U.S. national reference laboratory, offering PCR/NAAT-based infectious disease panels and routine molecular testing to physicians, hospitals, and SNFs. Operates a nationwide patient service center and logistics network that Labtest Bio's three facilities cannot match in convenience.
  • Mayo Clinic Laboratories: Hospital-affiliated national esoteric reference laboratory offering specialty molecular and infectious disease testing globally. Comparable as a reference laboratory serving clinicians with complex diagnostics, though anchored in academic hospital distribution rather than OBGYN/SNF channels.
  • BioReference Health (formerly BioReference Laboratories, an OPKO Health subsidiary): A national full-service clinical reference laboratory with a strong footprint in women's health, oncology, and infectious disease molecular diagnostics. Competes for similar OBGYN and specialty clinician customers with broader routine testing capabilities than Labtest Bio's infectious disease-focused menu.

Emerging players

  • Molecular Testing Labs: An independently owned molecular reference laboratory offering PCR-based STI, UTI, and women's health panels to clinicians with a similar focus on specialty infectious disease testing. A near-direct comparable in size and customer targeting to Labtest Bio's customizable panel model.

Direct peers

  • Viracor Eurofins: A specialty molecular and immunology reference laboratory with a similar focus on complex infectious disease and immune-mediated testing for clinicians. Competes head-to-head in NAAT-based infectious disease panels with a specialty-lab service model analogous to Labtest Bio's customization and rapid turnaround positioning.
  • Aegis Sciences Corporation: A specialty reference laboratory offering molecular infectious disease, toxicology, and pharmacogenomic testing with rapid turnaround to clinicians. Closely comparable mid-size specialty molecular lab competing for similar OBGYN, urgent care, and pain/ID physician relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

labtest.bio social profiles

Digital presence

labtest.bio compliance and trust

Trust signal

Compliance3 records

labtest.bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

labtest.bio leadership team

Management profile

Number of profiles

Profiles9 records

labtest.bio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

labtest.bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about labtest.bio

What does labtest.bio do?

Labtest Bio is a national molecular reference laboratory that delivers customizable NAAT (Nucleic Acid Amplification Test) diagnostic panels — covering UTIs, C. difficile, respiratory infections, GI infections, wound infections, vaginitis, candidiasis, nail fungus, STIs, and antibiotic resistance — to healthcare providers. Powered by proprietary ProAmpHT isothermal amplification technology and supported by free Pro LIMS EMR integration, the lab provides next-morning (24-hour) results with same-day sample pickup.

Is labtest.bio a public or private company?

labtest.bio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was labtest.bio founded?

labtest.bio was founded in -1. It employs 1 to 10 people.

Where is labtest.bio based?

labtest.bio is headquartered in Georgetown, United States, in the North America region.

How does labtest.bio make money?

Two revenue lines are on record. Molecular Diagnostic Testing Services are the primary driver. The others are affordable Cash Pay / Patient Payment Portal.

Who are labtest.bio's main competitors?

Broad incumbents on record are Quest Diagnostics, ARUP Laboratories, Laboratory Corporation of America (Labcorp), Mayo Clinic Laboratories and BioReference Health (formerly BioReference Laboratories, an OPKO Health subsidiary). Molecular Testing Labs is listed as an emerging player. Direct peers are Viracor Eurofins and Aegis Sciences Corporation.

Does labtest.bio have an API?

No public API is recorded for labtest.bio.

What industry is labtest.bio in?

labtest.bio's product category is Molecular Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales